Analytical Data
-
Gene name
TECTB
- Application
-
Alternative Names
Tectb; Beta-tectorin
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His-B2M-JD & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O08524
-
Expression Region
18-305aa
-
Molecular Weight
39.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TECTB, or Tectonic Protein B, is a recently studied recombinant protein that plays a crucial role in various cellular processes, including signal transduction and cytoskeletal dynamics. The exploration of TECTB has gained momentum due to its potential implications in understanding diseases linked to cell migration and differentiation, such as cancer and developmental disorders. Researchers have been investigating its structural and functional properties to elucidate its mechanism of action within cellular pathways. Recombinant technology has facilitated the production of TECTB in controlled environments, allowing for in-depth analysis of its biochemical properties. This has opened new avenues for drug development and therapeutic interventions by enabling the design of targeted approaches to modulate TECTB activity. With advancements in protein engineering and molecular biology techniques, the functional characterization of TECTB is anticipated to provide insights into its role in health and disease, further emphasizing the importance of recombinant proteins in biomedical research.
